Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Vehicle-saving theranostic probes based on hydrophobic iron oxide nanoclusters using doxorubicin as a phase transfer agent for MRI and chemotherapy
Yanbing
Cao†
a,
Juan
Min†
bd,
Dongye
Zheng
c,
Jiong
Li
c,
Yanan
Xue
*a,
Faquan
Yu
*a and
Ming
Wu
*bd
aKey Laboratory for Green Chemical Process of Ministry of Education, Hubei Key Laboratory for Novel Reactor and Green Chemistry Technology, Hubei Engineering Research Center for Advanced Fine Chemicals, and School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, P. R. China. E-mail: xueyn_wit@163.com; fyuwucn@gmail.com; fyu@wit.edu.cn
bThe United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China. E-mail: wmmj0419@163.com
cKey Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China
dWuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, P. R. China
First published on 22nd July 2019
Abstract
Correction for ‘Vehicle-saving theranostic probes based on hydrophobic iron oxide nanoclusters using doxorubicin as a phase transfer agent for MRI and chemotherapy’ by Yanbing Cao et al., Chem. Commun., 2019, DOI: 10.1039/c9cc03868j.
The authors regret that the affiliations for Juan Min and Ming Wu were incorrect in the original article. The correct affiliations are as presented here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † Yanbing Cao and Juan Min contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2019 |